Realization of Targets for the Fiscal Year Ending March 2021 under the Third Medium-Term Management Plan
First written in FY2018. 15 of 19 entries say "Restated". Latest entry: FY2025-H1.
41 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「Under the newly launched 4-year Fifth Medium-Term Management Plan, which began in April 2024, we are addressing key issues over the medium to long term as the final phase toward achieving the target.」
The Company has continued addressing key issues under the Fifth Medium-Term Management Plan, a 4-year plan transitioned to from the Third and Fourth Medium-Term Management Plans. - FY2024ReframedAnnual report
「To achieve the ¥50 billion initiative, we formulated the Fifth Medium-Term Management Plan and have been implementing it since April 2024.」
Following the final year of the Fourth Medium-Term Management Plan, the Company transitioned to the Fifth Medium-Term Management Plan from April 2024. - FY2024-Q3RestatedAnnual report
「Specifically, we formulated the "Matsufu Group Fourth Medium-Term Management Plan" and will work to enhance corporate value and, consequently, the common interests of shareholders through priority measures including ① developing new products suited to local demand and needs, ② relocating production bases and expanding overseas production, ③ developing and establishing sales networks, sales bases and domestic and overseas academic networks, ④ developing and securing human resources to actively promote overseas expansion, ⑤ promoting M&A, ⑥ strengthening Group governance, and ⑦ entering into business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社.」
The priority measures of the Fourth Medium-Term Management Plan and the policy of achieving consolidated net sales of ¥50 billion and consolidated operating profit of ¥7.5 billion are reiterated. - FY2024-Q2RestatedAnnual report
「Specifically, we formulated the "Matsufu Group Fourth Medium-Term Management Plan" and will work to enhance corporate value and, consequently, the common interests of shareholders through priority measures including ① developing new products suited to local demand and needs, ② relocating production bases and expanding overseas production, ③ developing and establishing sales networks, sales bases and domestic and overseas academic networks, ④ developing and securing human resources to actively promote overseas expansion, ⑤ promoting M&A, ⑥ strengthening Group governance, and ⑦ entering into business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社.」
The priority measures of the Fourth Medium-Term Management Plan, including new products, production, sales and academic networks, human resources, M&A, Group governance, and business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社, are reiterated. - FY2024-Q1RestatedAnnual report
「Specifically, we formulated the "Matsufu Group Fourth Medium-Term Management Plan" and will work to enhance corporate value and, consequently, the common interests of shareholders through priority measures including ① developing new products suited to local demand and needs, ② relocating production bases and expanding overseas production, ③ developing and establishing sales networks, sales bases and domestic and overseas academic networks, ④ developing and securing human resources to actively promote overseas expansion, ⑤ promoting M&A, ⑥ strengthening Group governance, and ⑦ entering into business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社.」
The priority measures of the Fourth Medium-Term Management Plan, including new products, production, sales and academic networks, human resources, M&A, Group governance, and business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社, are reiterated. - FY2023Details of initiatives for the final year of the Fourth Medium-Term Management PlanAnnual report
「In fiscal 2023, the final year of the Fourth Medium-Term Management Plan, we will steadily implement the measures with a sense of urgency to achieve further growth for the Group.」
The Company has stated its policy of steadily implementing the priority measures in fiscal 2023, the final year of the Fourth Medium-Term Management Plan. - FY2023-Q3RestatedAnnual report
「Specifically, we formulated the "Matsufu Group Fourth Medium-Term Management Plan" and will work to enhance corporate value and, consequently, the common interests of shareholders through priority measures including ① developing new products suited to local demand and needs, ② relocating production bases and expanding overseas production, ③ developing and establishing sales networks, sales bases and domestic and overseas academic networks, ④ developing and securing human resources to actively promote overseas expansion, ⑤ promoting M&A, ⑥ strengthening Group governance, and ⑦ entering into business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社.」
The priority measures of the Fourth Medium-Term Management Plan, including new products, production, sales and academic networks, human resources, M&A, Group governance, and business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社, are reiterated. - FY2023-Q2RestatedAnnual report
「Specifically, we formulated the "Matsufu Group Fourth Medium-Term Management Plan" and will work to enhance corporate value and, consequently, the common interests of shareholders through priority measures including ① developing new products suited to local demand and needs, ② relocating production bases and expanding overseas production, ③ developing and establishing sales networks, sales bases and domestic and overseas academic networks, ④ developing and securing human resources to actively promote overseas expansion, ⑤ promoting M&A, ⑥ strengthening Group governance, and ⑦ entering into business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社.」
The priority measures of the Fourth Medium-Term Management Plan, including new products, production, sales and academic networks, human resources, M&A, Group governance, and business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社, are reiterated. - FY2023-Q1RestatedAnnual report
「Specifically, we formulated the "Matsufu Group Fourth Medium-Term Management Plan" and will work to enhance corporate value and, consequently, the common interests of shareholders through priority measures including ① developing new products suited to local demand and needs, ② relocating production bases and expanding overseas production, ③ developing and establishing sales networks, sales bases and domestic and overseas academic networks, ④ developing and securing human resources to actively promote overseas expansion, ⑤ promoting M&A, ⑥ strengthening Group governance, and ⑦ entering into business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社.」
The priority measures of the Fourth Medium-Term Management Plan, including products, production, sales, human resources, M&A, Group governance, and business alliances with Mitsui Chemicals,Inc. and サンメディカル株式会社, are reiterated. - FY2022-Q3RestatedAnnual report
「In addition, to achieve consolidated net sales of ¥50 billion and consolidated operating income of ¥7.5 billion, the Group will shift management resources overseas and focus on expanding its overseas business in order to capture demand in developed markets, mainly in Europe and the United States, and in emerging markets where living standards are expected to improve alongside economic growth. Its specific initiatives include formulating a medium-term management plan and pursuing priority measures such as ① developing new products tailored to regional demand and needs, ② relocating production bases and expanding overseas production, ③ establishing sales networks and sales bases and building domestic and international academic networks, and ④ developing and securing human resources to actively advance overseas expansion, thereby working to enhance corporate value and, in turn, the common interests of shareholders.」
After the transition to the Fourth Medium-Term Management Plan, the direction of the priority measures centered on overseas business expansion and combining product development, production, sales and academic networks, and human resources has been reiterated. - FY2022-Q2RestatedAnnual report
「In addition, to achieve consolidated net sales of ¥50 billion and consolidated operating income of ¥7.5 billion, the Group will shift management resources overseas and focus on expanding its overseas business in order to capture demand in developed markets, mainly in Europe and the United States, and in emerging markets where living standards are expected to improve alongside economic growth. Its specific initiatives include formulating a medium-term management plan and pursuing priority measures such as ① developing new products tailored to regional demand and needs, ② relocating production bases and expanding overseas production, ③ establishing sales networks and sales bases and building domestic and international academic networks, and ④ developing and securing human resources to actively advance overseas expansion, thereby working to enhance corporate value and, in turn, the common interests of shareholders.」
The direction of the priority measures centered on overseas business expansion has been reiterated after the transition to the Fourth Medium-Term Management Plan. - FY2022-Q1RestatedAnnual report
「As specific initiatives, the company formulated a medium-term management plan and will work to enhance corporate value and, consequently, the common interests of shareholders through key measures including (1) developing new products suited to regional demand and needs, (2) relocating production sites and expanding overseas production, (3) developing and establishing sales networks and sales locations and building domestic and overseas academic networks, and (4) developing and securing human resources to actively promote overseas expansion.」
The direction of the priority measures centered on overseas business expansion has been maintained after the transition to the Fourth Medium-Term Management Plan, with the priority measures of the Medium-Term Management Plan reiterated. - FY2021ReframedAnnual report
「Since then, 9 years have passed as we have formulated the First through Third Medium-Term Management Plans in 3-year cycles, with the aim of achieving the long-term vision, the ¥50 billion initiative. We have addressed many issues during this period, and from April 2021 we will continue working on the Fourth Medium-Term Management Plan toward achieving the vision.」
Following the final year of the Third Medium-Term Management Plan, the Company transitioned to the Fourth Medium-Term Management Plan from April 2021. - FY2021-Q3RestatedAnnual report
「As specific initiatives, the company formulated a medium-term management plan and will work to enhance corporate value and, consequently, the common interests of shareholders through key measures including (1) developing new products suited to regional demand and needs, (2) relocating production sites and expanding overseas production, (3) developing and establishing sales networks and sales locations and building domestic and overseas academic networks, and (4) developing and securing human resources to actively promote overseas expansion.」
The priority measures based on the Medium-Term Management Plan, including product development, production, sales and academic networks, and human resources, are reiterated. - FY2021-Q2RestatedAnnual report
「As specific initiatives, the company formulated a medium-term management plan and will work to enhance corporate value and, consequently, the common interests of shareholders through key measures including (1) developing new products suited to regional demand and needs, (2) relocating production sites and expanding overseas production, (3) developing and establishing sales networks and sales locations and building domestic and overseas academic networks, and (4) developing and securing human resources to actively promote overseas expansion.」
The priority measures based on the Medium-Term Management Plan, including overseas business expansion, product development, production, sales and academic networks, and human resources, are reiterated. - FY2020-Q1RestatedAnnual report
「In addition, to achieve consolidated net sales of ¥50 billion and consolidated operating income of ¥7.5 billion, the Group will shift management resources overseas and focus on expanding its overseas business in order to capture demand in developed markets, mainly in Europe and the United States, and in emerging markets where living standards are expected to improve alongside economic growth. Its specific initiatives include formulating a medium-term management plan and pursuing priority measures such as ① developing new products tailored to regional demand and needs, ② relocating production bases and expanding overseas production, ③ establishing sales networks and sales bases and building domestic and international academic networks, and ④ developing and securing human resources to actively advance overseas expansion, thereby working to enhance corporate value and, in turn, the common interests of shareholders.」
The priority measures based on the Medium-Term Management Plan, including overseas business expansion, product development, production, sales and academic networks, and human resources, are reiterated. - FY2019RestatedAnnual report
「In fiscal 2019, the second year of the Third Medium-Term Management Plan, we will steadily implement the various measures with a sense of urgency to secure the growth of the Group.」
The policy of continuing the Third Medium-Term Management Plan and implementing its measures in fiscal 2019, its second year, has been reaffirmed. - FY2019-Q3RestatedAnnual report
「With a view to the ideal state for 2022, the 100th anniversary of our founding, we will shift management resources overseas and focus on expanding our overseas business in order to capture demand in developed-country markets, particularly in Europe and the United States, and in emerging markets where living standards are expected to improve with economic growth. Specifically, we formulated a Medium-Term Management Plan and will work to enhance corporate value and, consequently, the common interests of shareholders through measures including ① developing new products suited to local demand and needs, ② relocating production bases and expanding overseas production, ③ developing and establishing sales networks and sales bases, and ④ developing and securing human resources to actively promote overseas expansion.」
The medium-term management plan and priority measures centered on overseas business expansion continue to be set out toward the long-term vision for 2022. - FY2018First statedAnnual report
「As a first step, we formulated the Third Medium-Term Management Plan through the fiscal year ending March 2021. Under this plan, while continuing our previous policy of increasing our presence in the domestic market, significantly shifting the allocation of management resources overseas and promoting the expansion of our overseas business, we will address the following priority issues.」
As an interim step toward the long-term targets for 2022, a new Third Medium-Term Management Plan through the fiscal year ending March 2021 was formulated, with overseas resource allocation, product development, sales networks, production, human resources, financing and M&A identified as priority issues.